FLT3 and acute myeloid leukemia: FLT3 is an oncogene in AML, which exhibits two types of mutations; internal tandem duplication (ITD) in 20–25% of patients, and tyrosine kinase domain (TKD) mutations in 5–10% of patients [6, 9].